Zent, C. S., Wang, X. V., Ketterling, R. P., Hanson, C. A., Libby, E. N., Barrientos, J. C., . . . Tallman, M. S. (2016). A Phase II Randomized Trial Comparing Standard and Low Dose Rituximab Combined with Alemtuzumab as Initial Treatment of Progressive Chronic Lymphocytic Leukemia in Older Patients: A Trial of the ECOG-ACRIN Cancer Research Group (E1908). Am J Hematol.
Citação norma ChicagoZent, Clive S., et al. "A Phase II Randomized Trial Comparing Standard and Low Dose Rituximab Combined With Alemtuzumab As Initial Treatment of Progressive Chronic Lymphocytic Leukemia in Older Patients: A Trial of the ECOG-ACRIN Cancer Research Group (E1908)." Am J Hematol 2016.
Citação norma MLAZent, Clive S., et al. "A Phase II Randomized Trial Comparing Standard and Low Dose Rituximab Combined With Alemtuzumab As Initial Treatment of Progressive Chronic Lymphocytic Leukemia in Older Patients: A Trial of the ECOG-ACRIN Cancer Research Group (E1908)." Am J Hematol 2016.